The synergistic effect of MYC and BCL-XL or BCL-2 overexpression on tumor development observed here is in agreement with previous observations in transgenic Eμ-MYC/BCL-2-induced B lymphoma [17], [18]. The gene discussed is MYC; the disease is neoplasm.